HIGHLIGHTS
- who: Carolin Selenz and collaborators from the Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany have published the article: EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer, in the Journal: (JOURNAL)
- what: The authors investigate the impact of inhibition by erlotinib on the TME and its effect on the antitumour response of the immune cell infiltrate. The authors aimed to improve the understanding of the limited efficacy of im4. The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.